{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:14:59Z","timestamp":1790813699727,"version":"4.1.0"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T00:00:00Z","timestamp":1683676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Multidrug-resistant (MDR) bacterial infection causes difficulty in the therapy of peritoneal dialysis-associated peritonitis (PDAP); however, there are few studies on multidrug-resistant organism (MDRO)-PDAP. In view of growing concerns about MDRO-PDAP, the aim of this study was to investigate the clinical features, risk factors of treatment failure, and causative pathogens of MDRO-PDAP.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In total, 318 patients who underwent PD between 2013 and 2019 were included in this multicenter retrospective study. Clinical features, patient outcomes, factors related to treatment failure, and microbiological profiles associated with MDRO-PDAP were analyzed and risk factors for treatment failure associated with MDR-<jats:italic>Escherichia coli (E. coli)<\/jats:italic> were further discussed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of 1,155 peritonitis episodes, 146 eligible episodes of MDRO-PDAP, which occurred in 87 patients, were screened. There was no significant difference in the composition ratio of MDRO-PDAP between 2013\u20132016 and 2017\u20132019 (<jats:italic>p<\/jats:italic>\u2009&amp;gt;\u20090.05). <jats:italic>E. coli<\/jats:italic> was the most prevalent MDRO-PDAP isolate, with high sensitivity to meropenem (96.0%) and piperacillin\/tazobactam (89.1%). <jats:italic>Staphylococcus aureus<\/jats:italic> was the second most common isolate and was susceptible to vancomycin (100%) and linezolid (100%). Compared to non-multidrug-resistant organism-PDAP, MDRO-PDAP was associated with a lower cure rate (66.4% vs. 85.5%), higher relapse rate (16.4% vs. 8.0%), and higher treatment failure rate (17.1% vs.6.5%). Dialysis age [odds ratio (OR): 1.034, 95% confidence interval (CI): 1.016\u20131.052, <jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.001] and\u2009&amp;gt;2 previous peritonitis episodes (OR: 3.400, 95% CI: 1.014\u201311.400, <jats:italic>p<\/jats:italic>\u2009=\u20090.047) were independently associated with treatment failure. Furthermore, longer dialysis age (OR: 1.033, 95% CI: 1.003\u20131.064, <jats:italic>p<\/jats:italic>\u2009=\u20090.031) and lower blood albumin level (OR: 0.834, 95% CI: 0.700\u20130.993, <jats:italic>p<\/jats:italic>\u2009=\u20090.041) increased the risk of therapeutic failure for MDR-<jats:italic>E. coli<\/jats:italic> infection.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The proportion of MDRO-PDAP has remained high in recent years. MDRO infection is more likely to result in worse outcomes. Dialysis age and previous multiple peritonitis infections were significantly associated with treatment failure. Treatment should be promptly individualized based on local empirical antibiotic and drug sensitivity analyses.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2023.1132695","type":"journal-article","created":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T12:22:29Z","timestamp":1683721349000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Multidrug-resistant organism-peritoneal dialysis associated peritonitis: clinical and microbiological features and risk factors of treatment failure"],"prefix":"10.3389","volume":"10","author":[{"given":"Shizheng","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingfei","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengmao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenpeng","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,10]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1053\/j.ajkd.2015.05.001","article-title":"Us renal data system 2014 annual data report: epidemiology of kidney disease in the United States","volume":"66","author":"Saran","year":"2015","journal-title":"Am J Kidney Diseases"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"425","DOI":"10.4103\/ijn.IJN_73_19","article-title":"Continuous ambulatory peritoneal dialysis peritonitis guidelines - consensus statement of peritoneal dialysis Society of India - 2020","volume":"31","author":"Jeloka","year":"2021","journal-title":"Ind J Nephrology"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"e5569","DOI":"10.1097\/MD.0000000000005569","article-title":"Risk factors and outcomes of high peritonitis rate in continuous ambulatory peritoneal dialysis patients: a retrospective study","volume":"95","author":"Tian","year":"2016","journal-title":"Medicine"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"72","DOI":"10.4103\/ijmm.IJMM_20_251","article-title":"Continuous ambulatory peritoneal dialysis peritonitis: microbiology and outcomes","volume":"38","author":"Pindi","year":"2020","journal-title":"Indian J Med Microbiol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"723","DOI":"10.3265\/Nefrologia.pre2011.Oct.10987","article-title":"Impact of peritonitis on long-term survival of peritoneal dialysis patients","volume":"31","author":"Bustillo","year":"2011","journal-title":"Nefrolog\u00eda Publicaci\u00f3n Oficial De La Sociedad Espaola Nefrologia"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.jinf.2020.05.033","article-title":"Prevalence and associated factors for carriage of Enterobacteriaceae producing Esbls or Carbapenemase and methicillin-resistant staphylococcus Aureus in Hong Kong community","volume":"81","author":"Kwok","year":"2020","journal-title":"J Infect"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1002\/jobm.202100061","article-title":"Antibacterial activities of Hexadecanoic acid methyl ester and green-synthesized silver nanoparticles against multidrug-resistant bacteria","volume":"61","author":"Shaaban","year":"2021","journal-title":"J Basic Microbiol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3747\/pdi.2016.00123","article-title":"Epidemiology and clinical characteristics of acinetobacter peritoneal dialysis-related peritonitis in Hong Kong-with a perspective on multi-drug and carbapenem resistance","volume":"37","author":"Li","year":"2017","journal-title":"Perit Dial Int"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3747\/pdi.2012.00198","article-title":"Peritoneal dialysis-related peritonitis with acinetobacter baumannii: a review of seven cases","volume":"34","author":"Zhang","year":"2014","journal-title":"Perit Dial Int"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/1744-9987.13564","article-title":"Peritoneal dialysis-related peritonitis due to corynebacterium striatum: an emerging multidrug-resistant pathogen","volume":"25","author":"Kitayama","year":"2021","journal-title":"Ther Apher Dial"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1089\/sur.2012.195","article-title":"Effects of age and diabetes mellitus on clinical outcomes in patients with peritoneal dialysis-related peritonitis","volume":"14","author":"Tsai","year":"2013","journal-title":"Surg Infect"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"e14385","DOI":"10.1097\/MD.0000000000014385","article-title":"Risk factors associated with outcomes of peritoneal dialysis in Taiwan: an analysis using a competing risk model","volume":"98","author":"Chen","year":"2019","journal-title":"Medicine"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1186\/s12879-017-2754-5","article-title":"Risk factors for multidrug-resistant pathogens in bronchiectasis exacerbations","volume":"17","author":"Men\u00e9ndez","year":"2017","journal-title":"BMC Infect Dis"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1177\/08968608221080586","article-title":"ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment","volume":"42","author":"Li","year":"2022","journal-title":"Perit Dial Int"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and Pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3760\/cma.j.issn.1001-7097.2018.02.010","article-title":"Guidelines for the prevention and treatment of peritoneal dialysis-associated infections","volume":"34","author":"Yu","year":"2018","journal-title":"Chinese J Nephrol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ekir.2016.05.003","article-title":"The relationship between presentation and the time of initial administration of antibiotics with outcomes of peritonitis in peritoneal dialysis patients: the prompt study","volume":"1","author":"Muthucumarana","year":"2016","journal-title":"Kidney Int Rep"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/1744-9987.13956","article-title":"Clinical features and risk factors of catheter removal among 1062 episodes of peritoneal dialysis-associated peritonitis: a multicenter 7-year study","author":"Liu","year":"2022","journal-title":"Ther Apher Dial"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1167\/tvst.10.9.26","article-title":"Multidrug-resistant pseudomonas aeruginosa triggers differential inflammatory response in patients with endophthalmitis","volume":"10","author":"Naik","year":"2021","journal-title":"Transl Vis Sci Technol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1159\/000510552","article-title":"Neutrophil to lymphocyte ratio as a predictor of long-term outcome in peritoneal dialysis patients: a 5-year cohort study","volume":"50","author":"Zhang","year":"2021","journal-title":"Blood Purif"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1080\/0886022X.2021.1949350","article-title":"Peritoneal transport status and first episode of peritonitis: a large cohort study","volume":"43","author":"Hu","year":"2021","journal-title":"Ren Fail"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3747\/pdi.2015.00141","article-title":"Risk of peritoneal dialysis-related peritonitis in a multi-racial Asian population","volume":"37","author":"Ong","year":"2017","journal-title":"Perit Dial Int"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.jhin.2012.10.008","article-title":"Low prevalence of Meticillin-resistant staphylococcus aureus carriage at hospital admission: implications for risk-factor-based vs. universal screening","volume":"83","author":"Otter","year":"2013","journal-title":"J Hosp Infect"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.cmi.2022.03.014","article-title":"Exposure to who aware antibiotics and isolation of multi-drug resistant bacteria: a systematic review and meta-analysis","volume":"28","author":"Sulis","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"188","DOI":"10.3747\/pdi.2012.00233","article-title":"Microbiology and outcomes of peritonitis in northern India","volume":"34","author":"Prasad","year":"2014","journal-title":"Peritoneal Dialysis Int: J Int Soc Peritoneal Dialysis"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2215\/CJN.03180906","article-title":"Staphylococcus aureus peritonitis complicates peritoneal dialysis: review of 245 consecutive cases","volume":"2","author":"Szeto","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.12122\/j.issn.1673-4254.2020.12.07","article-title":"Clinical characteristics and treatment outcomes of first peritonitis in patients receiving long-term peritoneal dialysis: a multicenter study","volume":"40","author":"Zhao","year":"2020","journal-title":"J Southern Med Univ"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1177\/089686080402400616","article-title":"Analysis of the prevalence and causes of ultrafiltration failure during long-term peritoneal dialysis: a cross-sectional study","volume":"24","author":"Smit","year":"2004","journal-title":"Perit Dial Int"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1681\/ASN.2006111292","article-title":"Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions","volume":"18","author":"Aroeira","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3760\/cma.j.issn.1674-2397.2021.03.002","article-title":"Risk factors for the occurence and treatment failure of peritonral dialysis-associated E-coli peritonitis","volume":"14","author":"Cheng","year":"2021","journal-title":"Chinese J Clin Infect Diseases"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4102\/sajid.v35i1.104","article-title":"The prevalence and bacterial distribution of peritonitis amongst adults undergoing continuous ambulatory peritoneal dialysis at Universitas hospital","volume":"35","author":"Moola","year":"2020","journal-title":"South Afr J Infect Dis"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.jmii.2018.10.013","article-title":"Microbiology of peritoneal dialysis-related infection and factors of refractory peritoneal dialysis related peritonitis: a ten-year single-center study in Taiwan","volume":"52","author":"Wang","year":"2019","journal-title":"J Microbiol Immunol Infect"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3747\/pdi.2008.00258","article-title":"Staphylococcus aureus peritonitis in Australian peritoneal dialysis patients: predictors, treatment, and outcomes in 503 cases","volume":"30","author":"Govindarajulu","year":"2010","journal-title":"Perit Dial Int"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1038\/sj.ki.5000037","article-title":"Enterobacteriaceae peritonitis complicating peritoneal dialysis: a review of 210 consecutive cases","volume":"69","author":"Szeto","year":"2006","journal-title":"Kidney Int"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1128\/CMR.05035-11","article-title":"Carbapenemases in Klebsiella Pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions","volume":"25","author":"Tzouvelekis","year":"2012","journal-title":"Clin Microbiol Rev"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1093\/cid\/cir202","article-title":"Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention","volume":"53","author":"Weinstein","year":"2011","journal-title":"Clin Infect Diseases: Off Publ Infect Diseases Soc Am"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1469-0691.2012.04001.x","article-title":"The polymicrobial nature of biofilm infection","volume":"19","author":"Wolcott","year":"2013","journal-title":"Clin Microbiol Infect"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1132695\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T12:23:15Z","timestamp":1683721395000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1132695\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,10]]},"references-count":37,"alternative-id":["10.3389\/fmed.2023.1132695"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2023.1132695","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,10]]},"article-number":"1132695"}}